{"id":5699,"date":"2022-06-15T11:16:38","date_gmt":"2022-06-15T11:16:38","guid":{"rendered":"https:\/\/grupo.us.es\/farmolap\/web\/beta\/?page_id=5699"},"modified":"2022-07-06T08:38:02","modified_gmt":"2022-07-06T08:38:02","slug":"contratos","status":"publish","type":"page","link":"https:\/\/grupo.us.es\/farmolap\/web\/que-hacemos\/contratos\/","title":{"rendered":"Contratos"},"content":{"rendered":"

Contratos<\/h1>\n<\/div><\/div><\/div><\/div><\/div><\/div><\/section>
\n\n\n\n\n\n\n\n\n
\n

Fecha de inicio<\/h4>\n<\/td>\n

\n

Fecha de fin<\/h4>\n<\/td>\n

\n

Denominaci\u00f3n<\/h4>\n<\/td>\n

\n

Agencia financiadora<\/h4>\n<\/td>\n<\/tr>\n

1-2-2013<\/td>\n30-6-2013<\/td>\nEfectos de un extracto de algas\/aceites de frutas sobre los fenotipos de longevidad y obesidad utilizando el organismo modelo Caenorhabditis elegans (ACR\u00d3NIMO POLINAT 2013).\u00a0(1784\/0151)<\/a><\/td>\nPOLIFENOLES NATURALES, S.L. (POLINAT)<\/td>\n<\/tr>\n
1-1-2011<\/td>\n30-12-2011<\/td>\nEffects of the ptobiotic VSL 3 on experimental intestinal colitis-associated carcinogenesis\u00a0(1058\/0151)<\/a><\/td>\nActial Farmac\u00e9utica<\/td>\n<\/tr>\n
30-11-2009<\/td>\n30-6-2011<\/td>\nProducci\u00f3n y valoraci\u00f3n de bimasa a partir de microalgas; Sub-proyecto A-6-3. Estudio de obtenci\u00f3n y valoraci\u00f3n de productos naturales a partir de la biomasa residual: usos farmac\u00e9uticos.\u00a0(0632\/0151)<\/a><\/td>\nBIOTECNOLOG\u00cdA DE MICROALGAS, S.L.<\/td>\n<\/tr>\n
1-10-2008<\/td>\n30-6-2009<\/td>\nEstudio de obtenci\u00f3n y valorizaci\u00f3n de biomasa a partir de microalgas\u00a0(0245\/0151)<\/a><\/td>\nAurantia 2003, S.L.<\/td>\n<\/tr>\n
17-7-2002<\/td>\n18-12-2002<\/td>\nEstudio inmunohistoqu\u00edmico y molecular de los factores reguladores de la angiog\u00e9nesis, proliferaci\u00f3n y apoptosis en un modelo de \u00falcera cr\u00f3nica experimental\u00a0(OG-121\/02)<\/a><\/td>\nZambon, S.A.<\/td>\n<\/tr>\n
1-12-2000<\/td>\n1-12-2001<\/td>\nEfectos de ibuprofeno – L-Arginina y Rocecoxib, inhibidor COX sobre las lesiones inducidas previamente en la rata de forma cr\u00f3nica con \u00e1cido clorh\u00eddrico\u00a0(OG-007\/01)<\/a><\/td>\nZambon, S.A.<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div><\/div><\/div><\/div><\/div><\/div><\/section>\n","protected":false},"excerpt":{"rendered":"Contratos Fecha de inicio Fecha de fin Denominaci\u00f3n Agencia financiadora 1-2-2013 30-6-2013 Efectos de un extracto de algas\/aceites de frutas sobre los fenotipos de longevidad y obesidad utilizando el organismo modelo Caenorhabditis elegans (ACR\u00d3NIMO POLINAT 2013).\u00a0(1784\/0151) POLIFENOLES NATURALES, S.L. (POLINAT) 1-1-2011 30-12-2011 Effects of the ptobiotic VSL 3 on experimental intestinal colitis-associated carcinogenesis\u00a0(1058\/0151) Actial Farmac\u00e9utica...","protected":false},"author":8,"featured_media":0,"parent":5174,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":[],"_links":{"self":[{"href":"https:\/\/grupo.us.es\/farmolap\/web\/wp-json\/wp\/v2\/pages\/5699"}],"collection":[{"href":"https:\/\/grupo.us.es\/farmolap\/web\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/grupo.us.es\/farmolap\/web\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/grupo.us.es\/farmolap\/web\/wp-json\/wp\/v2\/users\/8"}],"replies":[{"embeddable":true,"href":"https:\/\/grupo.us.es\/farmolap\/web\/wp-json\/wp\/v2\/comments?post=5699"}],"version-history":[{"count":8,"href":"https:\/\/grupo.us.es\/farmolap\/web\/wp-json\/wp\/v2\/pages\/5699\/revisions"}],"predecessor-version":[{"id":5765,"href":"https:\/\/grupo.us.es\/farmolap\/web\/wp-json\/wp\/v2\/pages\/5699\/revisions\/5765"}],"up":[{"embeddable":true,"href":"https:\/\/grupo.us.es\/farmolap\/web\/wp-json\/wp\/v2\/pages\/5174"}],"wp:attachment":[{"href":"https:\/\/grupo.us.es\/farmolap\/web\/wp-json\/wp\/v2\/media?parent=5699"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}